Hsbc Holdings PLC trimmed its position in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 59.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,222 shares of the business services provider's stock after selling 15,280 shares during the period. Hsbc Holdings PLC's holdings in Exponent were worth $830,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also recently modified their holdings of the company. Envestnet Asset Management Inc. increased its position in shares of Exponent by 2.0% during the 1st quarter. Envestnet Asset Management Inc. now owns 441,646 shares of the business services provider's stock valued at $35,800,000 after purchasing an additional 8,501 shares during the last quarter. Entropy Technologies LP bought a new position in shares of Exponent during the 1st quarter valued at approximately $547,000. Bessemer Group Inc. grew its position in Exponent by 103.3% in the 1st quarter. Bessemer Group Inc. now owns 681 shares of the business services provider's stock valued at $55,000 after acquiring an additional 346 shares during the last quarter. SG Americas Securities LLC bought a new position in Exponent in the 1st quarter valued at $665,000. Finally, Fifth Third Bancorp grew its position in Exponent by 14.4% in the 1st quarter. Fifth Third Bancorp now owns 6,835 shares of the business services provider's stock valued at $554,000 after acquiring an additional 858 shares during the last quarter. Institutional investors own 92.37% of the company's stock.
Insider Buying and Selling at Exponent
In other Exponent news, VP Joseph Sala sold 1,595 shares of the company's stock in a transaction on Tuesday, August 12th. The stock was sold at an average price of $70.64, for a total value of $112,670.80. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Catherine Corrigan sold 4,896 shares of the company's stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $71.09, for a total value of $348,056.64. Following the completion of the transaction, the chief executive officer directly owned 81,342 shares in the company, valued at $5,782,602.78. This trade represents a 5.68% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company's stock.
Exponent Stock Performance
Exponent stock traded down $0.08 during mid-day trading on Wednesday, hitting $71.85. The company's stock had a trading volume of 479,853 shares, compared to its average volume of 328,995. The company has a 50 day moving average of $72.44 and a 200-day moving average of $77.07. The stock has a market cap of $3.63 billion, a PE ratio of 35.93 and a beta of 0.94. Exponent, Inc. has a one year low of $63.81 and a one year high of $115.75.
Exponent (NASDAQ:EXPO - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The business services provider reported $0.52 EPS for the quarter, beating the consensus estimate of $0.48 by $0.04. The company had revenue of $132.87 million for the quarter, compared to the consensus estimate of $130.82 million. Exponent had a return on equity of 24.19% and a net margin of 18.35%.Exponent's quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.57 EPS. On average, equities research analysts forecast that Exponent, Inc. will post 1.98 EPS for the current fiscal year.
Exponent Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 19th. Shareholders of record on Friday, September 5th will be given a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Friday, September 5th. Exponent's dividend payout ratio is 60.00%.
About Exponent
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Recommended Stories

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.